首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Intra-membrane Oligomerization and Extra-membrane Oligomerization of Amyloid-β Peptide Are Competing Processes as a Result of Distinct Patterns of Motif Interplay
【2h】

Intra-membrane Oligomerization and Extra-membrane Oligomerization of Amyloid-β Peptide Are Competing Processes as a Result of Distinct Patterns of Motif Interplay

机译:淀粉样β肽的膜内低聚和膜外低聚是竞争过程的母题相互作用的不同模式的结果。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Soluble oligomers of amyloid-β peptide (Aβ) are emerging as the primary neurotoxic species in Alzheimer disease, however, whether the membrane is among their direct targets that mediate the downstream adverse effects remains elusive. Herein, we show that multiple soluble oligomeric Aβ preparations, including Aβ-derived diffusible ligand, protofibril, and zinc-induced Aβ oligomer, exhibit much weaker capability to insert into the membrane than Aβ monomer. Aβ monomers prefer incorporating into membrane rather than oligomerizing in solution, and such preference can be reversed by the aggregation-boosting factor, zinc ion. Further analyses indicate that the membrane-embedded oligomers of Aβ are derived from rapid assembly of inserted monomers but not due to the insertion of soluble Aβ oligomers. By comparing the behavior of a panel of Aβ truncation variants, we demonstrate that the intra- and extra-membrane oligomerization are mutually exclusive processes that proceed through distinct motif interplay, both of which require the action of amino acids 37–40/42 to overcome the auto-inhibitory interaction between amino acids 29–36 and the N-terminal portion albeit via different mechanisms. These results indicate that intra- and extra-membrane oligomerization of Aβ are competing processes and emphasize a critical regulation of membrane on the behavior of Aβ monomer and soluble oligomers, which may determine distinct neurotoxic mechanisms.
机译:淀粉样蛋白-β肽(Aβ)的可溶性寡聚体已成为阿尔茨海默病的主要神经毒性物质,但是,该膜是否是其介导下游不良反应的直接靶标之一,目前尚不清楚。本文中,我们显示了多种可溶性低聚Aβ制剂,包括Aβ衍生的可扩散配体,原纤维和锌诱导的Aβ低聚物,与Aβ单体相比,其插入膜的能力要弱得多。 Aβ单体更喜欢掺入膜中而不是在溶液中低聚,并且这种偏好可以通过促进聚集的因子锌离子来逆转。进一步的分析表明,Aβ的膜嵌入低聚物源自插入单体的快速组装,而不是由于可溶性Aβ低聚物的插入而引起的。通过比较一组Aβ截短变体的行为,我们证明膜内和膜外寡聚是相互排斥的过程,通过不同的基序相互作用进行,这两个过程都需要氨基酸37-40 / 42的作用来克服氨基酸29–36与N末端部分之间的自动抑制相互作用,尽管机制不同。这些结果表明,Aβ的膜内和膜外低聚是相互竞争的过程,并强调了膜对Aβ单体和可溶性低聚物的行为的关键调节作用,这可能决定了不同的神经毒性机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号